EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

152 hedge funds and large institutions have $328M invested in Eagle Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 48 reducing their positions, and 19 closing their positions.

Holders
152
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
59
Reduced
48
Closed
19
Calls
$1.78M
Puts
$15K
Net Calls
+$1.77M
Net Calls Change
-$1.83M

Top Buyers

1
LSV Asset Management
1
LSV Asset Management
Illinois
$4.43M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$11.7M
3
Bank of Nova Scotia
3
Bank of Nova Scotia
Ontario, Canada
$2.49M
4
Allspring Global Investments
4
Allspring Global Investments
North Carolina
$4.4M
5
HF
5
HRT Financial
New York
$1.78M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$35.9M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$3.26M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$6.77M
4
Millennium Management
4
Millennium Management
New York
$2.62M
5
Citadel Advisors
5
Citadel Advisors
Florida
$3.32M
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
176
Simplex Trading
Illinois
– – – –
4 5 6 7
8